AI Semen Analysis
Male Fertility Assessment
DevelopmentActive
Key Facts
About illumicell AI
illumicell AI is an early-stage, AI-driven diagnostics company operating out of the Harvard Pagliuca Life Lab. The company has developed a proprietary technology platform that uses AI to analyze cellular behavior, generating significantly more data than standard tests. Its initial focus areas are AI-powered semen analysis for fertility and immune cell activation readouts for immuno-oncology and autoimmune disease monitoring. The company raised a $2M pre-seed round in 2025 and is collaborating with Harvard on research studies.
View full company profileTherapeutic Areas
Other Male Fertility Assessment Drugs
| Drug | Company | Phase |
|---|---|---|
| RoXsta™ Oxidative Stress Diagnostic | Memphasys | Phase 2 |
| Undisclosed Male Fertility Diagnostic | Arex Life Sciences | Research/Development |